Related Experiment Video

Updated: Jul 13, 2026

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

Quantitative analyses reveal the importance of regulated Hdmx degradation for p53 activation

Yunyuan V Wang1, Mark Wade, Eetsin Wong

  • 1Gene Expression Laboratory, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA. wahl@salk.edu

Proceedings of the National Academy of Sciences of the United States of America
|July 21, 2007
PubMed

Insights

The tumor suppressor P53 is activated upon DNA damage when its negative regulators, Hdm2 and Hdmx, decrease in stability. This shift allows P53 to function, controlling cell cycle arrest and apoptosis.

Area of Science:

  • Molecular Biology
  • Cellular Stress Response
  • Cancer Biology

Background:

  • P53 is a crucial tumor suppressor that orchestrates cellular responses to stress, including cell cycle arrest, senescence, apoptosis, and DNA repair.
  • Hdm2 and Hdmx are key negative regulators of P53; Hdm2 controls P53 protein levels, while both Hdm2 and Hdmx inhibit P53's transcriptional activity.
  • Quantitative data on the intracellular concentrations and subcellular localization of Hdm2 and Hdmx during stress responses are limited.

Purpose of the Study:

  • To investigate the quantitative intracellular concentrations and subcellular distributions of Hdm2 and Hdmx in relation to P53 during DNA damage.
  • To elucidate the regulatory mechanisms governing P53 activation following DNA damage, focusing on the roles of Hdm2 and Hdmx.

Main Methods:

  • Analysis of endogenous Hdm2 and Hdmx concentrations and subcellular localization in normal and cancer cells.
  • Quantitative measurements performed in cells before and after exposure to DNA-damaging agents.
  • Assessment of P53 nuclear abundance and the stability of Hdm2 and Hdmx under stress conditions.

Main Results:

  • In unstressed cells, the nuclear abundance of Hdm2 and Hdmx relative to P53 limits P53 activity.
  • Upon DNA damage, P53 accumulates in the nucleus, while the stability of Hdm2 and Hdmx is reduced.
  • The decreased stability of Hdm2 and Hdmx significantly impairs their ability to antagonize P53, irrespective of their absolute levels.

Conclusions:

  • The regulation of P53 activity is critically dependent on the balance between P53 and its inhibitors, Hdm2 and Hdmx.
  • DNA damage triggers a switch in Hdm2's function, shifting its ubiquitin ligase preference from P53 to itself and Hdmx.
  • This damage-activated switch in Hdm2 activity is a central mechanism for P53 activation, enabling crucial cellular protective responses.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Assays for the Degradation of Misfolded Proteins in Cells10:56

Assays for the Degradation of Misfolded Proteins in Cells

Published on: August 28, 2016

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...